⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL333433 | 0.74 | — | — | |
| SCHEMBL997674 | 0.70 | — | — | |
| SCHEMBL17130433 | 0.70 | — | — | |
| SCHEMBL28999591 | 0.70 | — | — | |
| SCHEMBL8261491 | 0.70 | — | — | |
| SCHEMBL6477231 | 0.70 | — | — | |
| SCHEMBL18520338 | 0.70 | — | — | |
| SCHEMBL4536370 | 0.70 | — | — | |
| SCHEMBL209653 | 0.70 | — | — | |
| SCHEMBL13455031 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4114649-B1 | METHOD FOR POST-PROCESSING AN ADDITIVELY MANUFACTURED PART | ADDITIVE MANUFACTURING TECH LTD (GB) | 2024-06-12 | — | — | EP | claimed |
| EP-2250156-B1 | PYRAZINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES | MERCK PATENT GMBH (DE) | 2015-05-06 | — | — | EP | claimed |
| CN-101675053-B | Phosphoinositide 3-kinase inhibitor compounds and methods of use | GENENTECH INC | 2014-03-12 | — | — | CN | claimed |
| EP-2268624-B1 | ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES | MERCK PATENT GMBH (DE) | 2013-07-31 | — | — | EP | claimed |
| CN-101675053-A | Phosphoinositide 3-kinase inhibitor compounds and methods of use | GENENTECH INC | 2010-03-17 | — | — | CN | claimed |
| CN-101415679-A | Water-soluble CC-1065 analogs and conjugates thereof | SINTAGAR B V (NL) | 2009-04-22 | — | — | CN | claimed |
| CN-101410366-A | Substituted bicyclic ring derivatives and uses thereof | ASAHI KASEI PHARMA CORP (JP) | 2009-04-15 | — | — | CN | claimed |
| WO-2008120098-A2 | PEPTIDE PRODRUGS | DIATOS (FR) | 2008-10-09 | — | — | WO | claimed |
| CN-1173946-C | Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound | ���µ�˹ҩ�﹫˾ | 2004-11-03 | — | — | CN | claimed |
| EP-1429810-A1 | TRANSPORTING OF TAXOID DERIVATIVES THROUGH THE BLOOD BRAIN BARRIER | SYNT:EM (FR) | 2004-06-23 | — | — | EP | claimed |
| WO-2003026701-A1 | TRANSPORTING OF TAXOID DERIVATIVES THROUGH THE BLOOD BRAIN BARRIER | SYNT:EM (FR) | 2003-04-03 | — | — | WO | claimed |
| WO-2003026700-A2 | COMPOSITIONS FOR TRANSPORTING ANTIBODIES THROUGH THE BLOOD BRAIN BARRIER AND THEIR USE FOR DIAGNOSING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES | SYNT:EM (FR) | 2003-04-03 | — | — | WO | claimed |
| CN-1289324-A | Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound | AVENTIS PHARMA INC (US) | 2001-03-28 | — | — | CN | claimed |
| US-20250369024-A1 | Acyloin Condensation Reactions, Enzymes, and Products Thereof | MOJIA BIOTECH PTE LTD (SG) | 2025-12-04 | — | — | US | disclosed |
| EP-4649157-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | Mojia Biotech Pte. Ltd. (SG) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024150067-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | MOJIA BIOTECH PTE. LTD. (SG) | 2024-07-18 | — | — | WO | disclosed |
| WO-1999059526-A2 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1998050342-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998050342-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| EP-0002635-A1 | Process for the preparation of thieno (2,3-c) and (3,2-c) pyridine derivatives, thieno (2,3-c) pyridine derivatives thus obtained, and their therapeutical use | Omnium Financier Aquitaine pour l'Hygiene et la Sante (SANOFI) (FR) | 1979-06-27 | — | — | EP | disclosed |